| Mundipharma Regulatory GmbH - Hydromorphone Mundipharma 50 mg, Injektions-/Infusionslösung |
| 70222 | | 04 | | Hydromorphone Mundipharma 50 mg | | Injektions-/Infusionslösung | | N02AA03 | | Hydromorphone | | 16.04.2025 | | |
|
| Composition |
| hydromorphoni hydrochloridum 50 mg corresp. hydromorphonum 44.33 mg, natrii citras dihydricus, acidum citricum, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.92 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | Active Agent | Dose |
|---|
| Hydromorphon Hydrochloride | 50 mg/ml correspond Hydromorphone 44.33 mg/ml |
| | | | Inactive agents |
|---|
| Citric Acid | | Acidum Hydrochloridum | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | 5 | | | A+ | | Yes | | 008 | 10 | | | A+ | | Yes |
|
